1Suppliers
1Customers
1Debt Items
17Related Chains

Source-Backed Evidence Depth

Ethos Technologies Inc. (LIFE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

13Total relationships
11Distinct source URLs
3High confidence
0.681Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Ethos Technologies Inc. Suppliers

TickerNameConfidenceEvidence
ALLO Allogene Therapeutics, Inc. 62% Reciprocal relationship from ALLO graph: Reciprocal relationship from LIFE graph: Reciprocal relationship from ALLO graph: is equal to nine times the total amount awarded and paid to the Company. Aft…

Ethos Technologies Inc. Customers

TickerNameConfidenceEvidence
CEVA CEVA, Inc. 80% Alias reverse search [Ethos]: CEVA 10-K (2026-02-27) mentions 'Ethos' in supplier context. Excerpt: mpact on our competitiveness: ● DSP, NPU, and processor IP vendors, including Arm, Cadence, Imagina…

Ethos Technologies Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
LIFE-DEBT Debt stack $2.1M 90% Market cache reports total debt of $2.1M.

Ethos Technologies Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Ethos Technologies Inc..

Ethos Technologies Inc. Ownership

HolderNameConfidenceEvidence
TMO TMO 85% Wikidata parent: Ethos Technologies Inc. ↔ Thermo Fisher Scientific Inc.
MITSUI-SUMITOMO-INSURANCE-COMPANY MITSUI-SUMITOMO-INSURANCE-COMPANY 72% Wikidata parent: Ethos Technologies Inc. ↔ Mitsui Sumitomo Insurance Company
TRUG TRUG 62% Alias reverse search [Ethos]: TRUG 10-K (2026-04-15) mentions 'Ethos' in partner context. Excerpt: THER CURRENT LIABILITIES 2025 2024 Accrued payroll $ 1,478 $ 108,945 Credit cards 434,374 55,180 War…
JSDA JSDA 62% Alias reverse search [Ethos]: JSDA 10-K (2026-03-31) mentions 'Ethos' in partner context. Excerpt: rs seeking premium beverages with differentiated flavors and ingredients. A distinctive feature of t…
NOMA NOMA 62% Alias reverse search [Ethos]: NOMA 10-K (2026-03-31) mentions 'Ethos' in partner context. Excerpt: nnection to the legend, providing an immersive experience that goes beyond mere merchandise to inclu…
QUAD QUAD 62% Alias reverse search [Ethos]: QUAD 10-K (2026-02-18) mentions 'Ethos' in partner context. Excerpt: empowers each employee to think like an owner and maintain a client-first attitude, going beyond exp…
SSP SSP 62% Alias reverse search [Ethos]: SSP 10-K (2026-02-27) mentions 'Ethos' in partner context. Excerpt: rovided to the full Board for educational purposes or when special needs arise. Our Cyber Risk Manage…
CSV CSV 62% Alias reverse search [Ethos]: CSV 10-K (2026-02-26) mentions 'Ethos' in partner context. Excerpt: sizing strategic and thoughtful planning. This approach to business development is not about increasi…
WTM WTM 62% Alias reverse search [Ethos]: WTM 10-K (2026-02-27) mentions 'Ethos' in partner context. Excerpt: n as core agency partners. Complementing its M&A capabilities and capital solutions, BroadStreet prov…
LMND LMND 62% Alias reverse search [Ethos]: LMND 10-K (2026-02-25) mentions 'Ethos' in partner context. Excerpt: rs under our Giveback program. The Giveback is not a contractual obligation to any customer or to an…

Ethos Technologies Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ALLO Allogene Therapeutics, Inc. 100.00 1 ['supplier']
CRBU Caribou Biosciences, Inc. 50.00 2
AZN AstraZeneca PLC 50.00 2
FATE Fate Therapeutics, Inc. 50.00 2
ARTV Artiva Biotherapeutics, Inc. 50.00 2
CLLS Cellectis S.A. 50.00 2
CELU Celularity Inc. 50.00 2
GDTC CytoMed Therapeutics Limited 50.00 2
INAB IN8bio, Inc. 50.00 2
SI Shoulder Innovations, Inc. 50.00 2
JPM-PD JPMorgan Chase & Co. 50.00 2
MYGN Myriad Genetics, Inc. 50.00 2
TCRX TScan Therapeutics, Inc. 50.00 2
NTLA Intellia Therapeutics, Inc. 50.00 2
PFE Pfizer Inc. 50.00 2
CELUW Celularity Inc 50.00 2
PFIZER PFIZER 50.00 2
🔐
LIFE
Unlock LIFE Supply Chain Data
Verified relationships include:
ALLOAllogene Therapeutics, Inc.Supplier62%
CEVACEVA, Inc.Customer80%
+9 more relationships locked
Subscribe, View plans →